Astrazeneca boss Pascal Soriot (pictured) has pitched the deal as a way for the Covid vaccine maker to gain a foothold in potentially lucrative treatments for rare diseases,

Read the full article >>

Source: Daily Mail

"/>

Astrazeneca wins all-clear to swoop on rare disease drug firm Alexion